Cargando…
Association of respiratory failure with inhibition of NaV1.6 in the phrenic nerve
As part of a drug discovery effort to identify potent inhibitors of NaV1.7 for the treatment of pain, we observed that inhibitors produced unexpected cardiovascular and respiratory effects in vivo. Specifically, inhibitors administered to rodents produced changes in cardiovascular parameters and res...
Autores principales: | Klein, Rebecca M., Layton, Mark E., Regan, Hillary, Regan, Christopher P., Li, Yuxing, Filzen, Tracey, Cato, Matt, Clements, Michelle K., Wang, Jixin, Sanoja, Raul, Greshock, Thomas J., Roecker, Anthony J., Pero, Joseph E., Kim, Ron, Burgey, Christopher, John, Christopher T., Wang, Ying-Hong, Bhandari, Neetesh, Struyk, Arie, Kraus, Richard L., Henze, Darrell A., Houghton, Andrea K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578445/ https://www.ncbi.nlm.nih.gov/pubmed/36239534 http://dx.doi.org/10.1080/19336950.2022.2122309 |
Ejemplares similares
-
Application of Pharmacokinetic-Pharmacodynamic Modeling to Inform Translation of In Vitro NaV1.7 Inhibition to In Vivo Pharmacological Response in Non-human Primate
por: Ballard, Jeanine E., et al.
Publicado: (2020) -
Translational Pharmacokinetic–Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose
por: Ballard, Jeanine E., et al.
Publicado: (2021) -
Gating Pore Currents in DIIS4 Mutations of NaV1.4 Associated with Periodic Paralysis: Saturation of Ion Flux and Implications for Disease Pathogenesis
por: Struyk, Arie F., et al.
Publicado: (2008) -
Programming Microsoft Dynamics NAV: hone your skills and increase your productivity when programming in Microsoft Dynamics NAV 2017
por: Brummel, Mark, et al.
Publicado: (2017) -
Diagnosis and treatment of phrenic nerve hourglass constriction in patients with Parsonage-Turner syndrome
por: CreveCoeur, Travis S., et al.
Publicado: (2023)